2026 Updates in Cancer Therapies | Immunotherapy in Early-Stage NSCLC: Facts and The Unknown

2026 Updates in Cancer Therapies | Immunotherapy in Early-Stage NSCLC: Facts and The Unknown

Overview

NA

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Christine Lovly, MD, PhD, FASCO

Date of Release

January 16th, 2026